Stocks and Investing Stocks and Investing
Fri, December 8, 2023
Thu, December 7, 2023

Danielle Brill Upgraded (BIIB) to Buy and Held Target at $283 on, Dec 7th, 2023


Published on 2024-10-28 07:54:15 - WOPRAI, Danielle Brill
  Print publication without navigation


Danielle Brill of Raymond James, Upgraded "Biogen Inc." (BIIB) to Buy and Held Target at $283 on, Dec 7th, 2023.

Danielle has made no other calls on BIIB in the last 4 months.



There are 12 other peers that have a rating on BIIB. Out of the 12 peers that are also analyzing BIIB, 3 agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $239 on, Thursday, November 9th, 2023
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $275 on, Tuesday, August 8th, 2023
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $294 on, Tuesday, August 8th, 2023


These are the ratings of the 9 analyists that currently disagree with Danielle


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $373 on, Friday, November 10th, 2023
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $365 on, Thursday, November 9th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $363 on, Thursday, November 9th, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $295 on, Thursday, November 9th, 2023
  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $305 on, Thursday, October 26th, 2023
  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $360 on, Wednesday, September 6th, 2023
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $335 on, Monday, August 14th, 2023
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $340 on, Tuesday, August 8th, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $290 on, Monday, August 7th, 2023
Contributing Sources